
Chief Complaint
Transplant Diagnosis : Multiple Myeloma .
Date of Transplant : 11/28/2012 .
Day Post - Transplant : 7 .


Interval History
Pt was seen earlier during the day in infusion after coming to triage for mild abd pain . By the time he was seen in infusion his pain had subsided as he noted his discomfort was relieved w / laying down . He continued to have mild nausea w / occasional emesis related to gag reflex . Intake was waning . He started treatment for cdiff yesterday and his diarrhea was " clear " but still fairly liquidy .

He received his platelets w / o any adverse issues but his temperature was noted to be slightly increased to 37.9 at the completion of his transfusion . He did not want to hang around as his ride had arrived . By the time he made it home he had some mild chills and took his temperature which was noted to be above 38.5 . He then returned to triage and he temperature remained above 38.3 . On return assessment , he continued to note mild chills w / o rigors . His post nasal drip persisted but no overt rhinorrhea or sinus tenderness . He continues to have a chronic COPD cough which had not changed in intensity or production . No CP or SOB . Vital signs were stable

He was given on dose of Ceftazidime and had blood and urine cxs obtained prior to antibiotics . He was then sent to the university of washington for further medical care
.

Pain Management
Pain Scale : chronic dull back pain at rod placement . uses muscle relaxant at night prn .


Transplant Status
TRANSPLANT TYPE : autologous peripheral blood stem cell transplant .
CMV SEROLOGY : Recipient positive .
PREPARATIVE REGIMEN : Myeloablative melphalan .


Allergies

penicillins



Medications
Medications reviewed on 12/5/2012 .

Scheduled Medications
cholecalciferol 1 , 000 units PO Daily ( Vitamin D3 1000 intl units oral capsule )
fluconazole 200 mg PO Daily ( fluconazole 200 mg oral tablet )
hydrochlorothiazide 25 mg PO Daily ( hydrochlorothiazide 25 mg oral tablet )
levofloxacin 750 mg PO Q24 Hours ( levofloxacin 750 mg oral tablet )
losartan 50 mg PO Daily ( losartan 50 mg oral tablet )
multivitamin with minerals 1 tab PO Daily ( multivitamin with minerals , no iron )
omeprazole 20 mg PO Daily Empty Stomach ( omeprazole 20 mg oral delayed release capsule )
pyridoxine 100 mg PO Daily ( pyridoxine 100 mg oral tablet )
sodium chloride 1000 mL + 40 meq KCl IV Daily : ( 250mL / hr . Via Apria ) ( Sodium Chloride 0.9 % intravenous solution Rx )
trazodone 100 mg PO QHS ( trazodone 100 mg oral tablet )
valacyclovir 500 mg PO Q12 Hours ( valacyclovir 500 mg oral tablet )
verapamil 240 mg PO Daily ( verapamil 240 mg / 24 hours oral capsule , extended release )

PRN Medications
albuterol 1 - 2 puffs Inhalation Q4 Hours PRN ( for wheeze / shortness of breath ) ( albuterol CFC free ( HFA ) 90 mcg / inh inhalation aerosol )
alprazolam 0.5 mg PO QPM PRN ( Insomnia ) ( alprazolam 0.5 mg oral tablet )
cyclobenzaprine 10 mg PO Daily PRN ( for muscle pain / spasm ) ( cyclobenzaprine 10 mg oral tablet )
loperamide 2 mg PO PRN : ( NTE 16 mg per day ) ( for diarrhea ) ( loperamide 2 mg oral capsule )




Review of Systems
CONSTITUTIONAL Symptoms : fever , chills , malaise , denies weakness .
ENMT : denies rhinorrhea , denies mucositis , denies sinus congestion , denies sore throat .
CARDIOVASCULAR Symptoms : denies chest pain , denies lightheadedness , denies swelling .
RESPIRATORY Symptoms : cough , denies shortness of breath .
GASTROINTESTINAL Symptoms : abdominal pain , nausea , vomiting , diarrhea .
MUSCULOSKELETAL Symptoms : negative .
PSYCHIATRIC Symptoms : denies anxiety , denies insomnia .
SKIN Symptoms : denies rash .
NEUROLOGIC Symptoms : denies headaches , denies dizziness .
HEME / LYMPH Symptoms : denies bleeding , denies bruising .


Physical Examination
Vital Signs Data .
38.5 degC High Temperature - C 12/05/2012 15:33
Automatic BP Method 12/05/2012 15:33
RIGHT , Arm , Upper BP Extremity 12/05/2012 15:33
37.9 degC High Temperature - C 12/05/2012 13:11
Oral Temperature Source 12/05/2012 13:11
114 bpm High Heart Rate 12/05/2012 13:11
18 br / min Respiratory Rate 12/05/2012 13:11
137 mmHg SBP - Noninvasive 12/05/2012 13:11
62 mmHg DBP - Noninvasive 12/05/2012 13:11
Automatic BP Method 12/05/2012 13:11
RIGHT , Arm , Upper BP Extremity 12/05/2012 13:11
End of Transfusion Vital Sign Reason 12/05/2012 13:11
CONSTITUTIONAL : no apparent distress .
MENTAL STATUS : alert and oriented x3 , normal mood / affect .
EYES : EOMI , normal sclera .
EARS , NOSE , MOUTH , and THROAT : normal mouth and dentition , normal oropharynx .
MUCOSITIS ( WHO Oral Toxicity Scale ) : Grade 0 : No mucositis .
RESPIRATORY / CHEST : normal respiratory effort , wheezes RML , RLL , LUL .
CARDIOVASCULAR : regular rate and rhythm , no murmur , rub or gallop .
GASTROINTESTINAL : normal bowel sounds , abdomen non-tender , abdomen non - distended .
MUSCULOSKELETAL : normal gait / stance .
SKIN : no rash , bruises or ulcers .


Laboratory Studies
Reviewed in ORCA . Viral / CMV Monitoring
No results in the past 7 days .


Assessment / Plan
56 M day 7 of auto PBSCT for IgG lambda Multiple Myeloma .

Disease :
Dx 'd IgG lambda multiple myeloma 4 / 2010 , with M - spike : 3
Recvd Vel / Dex 4 / 2010 thru 8 / 2010 .
Re-start Vel / Dex 5 / 2011
Recvd Revlimid 11 / 2011 , then added Dex as well 6 / 2012
Recvd Vel / CY / Dex x 3 cycles 8/10/2012 thru 9/25/2012
SPEP : 0.2 ( 8/29/12 ) ; = 0.1 ( 9/19/12 )

SPEP : 0.1 ( 10/11/12 ) ; UPEP ( 10 / 12 ) Negative
BMA ( 10 / 12 ) Flow : ( + ) 0.15 % abnml ; Path : Nl cyto and negative FISH .
BM MRI & Osteo Surv ( 10 / 15 ) Multiple stable lytic lesion .
Diagnostic LP on 10 / 23 neg by flow .
Aredia 10 / 19 .
Repeat SPEP w / Ifix 11 / 15 , faint oligoclonal banding present .

Heme
- Pancytopenic . Monitor counts daily for transfusions indicated .
- Warfarin for line prophylaxis on hold d / t thrombocytopenia .
- Thresholds : Plt > 20 K for hx epistaxis and retinal hemorrhage . HCT > 26 . No pre - meds for transfusions . Plts given today .
- Documented mutation for hemochromatosis , but no overt disease . Hx of elevated iron levels . Iron studies ( 10/15/12 ) are all normal .

ID :
- Neutropenic fever . Clinically and hemodynamically stable . Pt was given one dose of Ceftazidime prior to admission . Blood and urine cxs were obtained and CXR will be performed on admission .
- Continue po flagyl for CDiff diarrhea .
- Prophylactic valtrex ( hx velcade ) .
- Continue fluconazole prophylaxis .

PULM :
- PFT ( 10 / 12 ) DLCO 53 % .
- Seen by pulmonary , moderate severe obstructive pattern without significant bronchodilator response and moderately decreased DLCO . These findings are consistent with COPD secondary to tobacco use . As pt pulmonary status is functional and he is asymptomatic no intervention was warranted and he was cleared for transplant . Still smoking occasional cigarette .
- Mild wheeze on exam , but without SOB . Monitor closely .

CV :
- Chronic hypertension . Normotensive today . Continue Hydrochlorothiazide , Verapamil & Losartan .
- EKG ( 10 / 10 ) NSR ; Echo LVEF 69 %

GI :
- Mild abd pain . Likely d / t ongoing melphalan toxicities in addition to concurrent CDiff . Continue to monitor closely for additional source of fevers .
- GERD , controlled on Omeprazole .
- Hx of elevated LFTs . U / S ( 4 / 2010 ) shows fatty liver . LFTs presently wnl .
- Hyperbilirubinemia : resolved .

PSYCH :
- Insomnia , controlled with Trazadone QHS & Alpazolam QHS .

MSK :
- Chronic low back pain / stiffness , that was slightly worse after hospitalization , but now improved . Hx of spinal fusion with rod placement T6 - T10 , due to T8 insufficiency fracture in 1 / 2012 . Uses cyclobenzaprine as needed .

FEN :
- Nutritional and fluid impairment d / t chemotherapy toxicities . Continue daily hydration of 1 L NS daily and monitor fluid status closely .
- Hypokalemia , continue repletion in IVF .
- Hyomagnesemia . Continue repletion in IVF .
- Continues Vitamin B6 supplementation .

RRT :
- Mild nausea is controlled w / prn antiemetics .
- Diarrhea . Slightly improved w / treatment for CDiff . Continue to monitor for continued improvement .


Signature

Peter M . Johnson PA-C
Seattle Cancer Care Alliance / Fred Hutchinson Cancer Research Center